__timestamp | Evotec SE | Intra-Cellular Therapies, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 12404000 | 21226345 |
Thursday, January 1, 2015 | 18343000 | 87718074 |
Friday, January 1, 2016 | 18108000 | 93831530 |
Sunday, January 1, 2017 | 17614000 | 79419009 |
Monday, January 1, 2018 | 35619000 | 132166913 |
Tuesday, January 1, 2019 | 58432000 | 89124838 |
Wednesday, January 1, 2020 | 63945000 | 65782137 |
Friday, January 1, 2021 | 72200000 | 88845513 |
Saturday, January 1, 2022 | 76642000 | 134715000 |
Sunday, January 1, 2023 | 57519000 | 180142000 |
Cracking the code
In the competitive landscape of pharmaceutical research, the battle for innovation is often reflected in R&D spending. Over the past decade, Intra-Cellular Therapies, Inc. and Evotec SE have been at the forefront of this financial commitment. From 2014 to 2023, Intra-Cellular Therapies, Inc. consistently outpaced Evotec SE, with an average R&D expenditure nearly double that of its competitor. Notably, in 2023, Intra-Cellular Therapies, Inc. invested approximately 180% more in R&D than Evotec SE, highlighting its aggressive pursuit of groundbreaking therapies.
These trends underscore the strategic priorities of each company, with Intra-Cellular Therapies, Inc. focusing on rapid innovation and Evotec SE on sustainable growth.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Madrigal Pharmaceuticals, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Mesoblast Limited: Who Invests More in Innovation?
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Intra-Cellular Therapies, Inc. or Evotec SE: Who Manages SG&A Costs Better?
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?